Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial.
Bruner DW, Pugh SL, Lee WR, Hall WA, Dignam JJ, Low D, Swanson GP, Shah AB, Malone S, Michalski JM, Dayes IS, Seaward SA, Nguyen PL, Pisansky TM, Chen Y, Sandler HM, Movsas B. Bruner DW, et al. Among authors: movsas b. JAMA Oncol. 2019 May 1;5(5):664-670. doi: 10.1001/jamaoncol.2018.6752. JAMA Oncol. 2019. PMID: 30763425 Free PMC article. Clinical Trial.
Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > or = 10 NG/ML.
Hanks GE, Lee WR, Hanlon AL, Hunt M, Kaplan E, Epstein BE, Movsas B, Schultheiss TE. Hanks GE, et al. Among authors: movsas b. Int J Radiat Oncol Biol Phys. 1996 Jul 15;35(5):861-8. doi: 10.1016/0360-3016(96)00207-6. Int J Radiat Oncol Biol Phys. 1996. PMID: 8751393
A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.
Murray KJ, Scott C, Greenberg HM, Emami B, Seider M, Vora NL, Olson C, Whitton A, Movsas B, Curran W. Murray KJ, et al. Among authors: movsas b. Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):571-4. doi: 10.1016/s0360-3016(97)00341-6. Int J Radiat Oncol Biol Phys. 1997. PMID: 9336134 Clinical Trial.
Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial.
Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Konski AA, Movsas B, Greenberg RE, Uzzo RG, Ma CM, McNeeley SW, Buyyounouski MK, Price RA Jr. Pollack A, et al. Among authors: movsas b. Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):518-26. doi: 10.1016/j.ijrobp.2005.07.970. Epub 2005 Oct 19. Int J Radiat Oncol Biol Phys. 2006. PMID: 16242256 Free PMC article. Clinical Trial.
Quality-of-life outcomes in oncology.
Siddiqui F, Kachnic LA, Movsas B. Siddiqui F, et al. Among authors: movsas b. Hematol Oncol Clin North Am. 2006 Feb;20(1):165-85. doi: 10.1016/j.hoc.2006.01.003. Hematol Oncol Clin North Am. 2006. PMID: 16580562 Review.
378 results